BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) announced a monthly dividend on Friday, December 6th,NASDAQ Dividends reports. Investors of record on Monday, December 16th will be given a dividend of 0.2892 per share on Monday, December 23rd. This represents a $3.47 dividend on an annualized basis and a yield of 21.26%. The ex-dividend date of this dividend is Monday, December 16th. This is a boost from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10.
BlackRock Capital Allocation Term Trust Stock Performance
Shares of NYSE:BCAT traded up $0.01 during midday trading on Friday, reaching $16.32. The company’s stock had a trading volume of 528,946 shares, compared to its average volume of 356,651. The business’s fifty day simple moving average is $16.20 and its 200-day simple moving average is $16.32. BlackRock Capital Allocation Term Trust has a fifty-two week low of $14.68 and a fifty-two week high of $17.18.
Insider Activity
In other BlackRock Capital Allocation Term Trust news, major shareholder Saba Capital Management, L.P. sold 28,670 shares of the company’s stock in a transaction on Monday, October 21st. The shares were sold at an average price of $16.27, for a total transaction of $466,460.90. Following the completion of the sale, the insider now owns 14,888,870 shares in the company, valued at approximately $242,241,914.90. The trade was a 0.19 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In the last ninety days, insiders sold 723,927 shares of company stock valued at $11,925,047.
About BlackRock Capital Allocation Term Trust
–
See Also
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Overbought Stocks Explained: Should You Trade Them?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- P/E Ratio Calculation: How to Assess Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.